These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35439935)

  • 1. Integrative analysis of mutated genes and mutational processes reveals novel mutational biomarkers in colorectal cancer.
    Dashti H; Dehzangi I; Bayati M; Breen J; Beheshti A; Lovell N; Rabiee HR; Alinejad-Rokny H
    BMC Bioinformatics; 2022 Apr; 23(1):138. PubMed ID: 35439935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer.
    Ghareyazi A; Mohseni A; Dashti H; Beheshti A; Dehzangi A; Rabiee HR; Alinejad-Rokny H
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer types.
    Ghareyazi A; Kazemi A; Hamidieh K; Dashti H; Tahaei MS; Rabiee HR; Alinejad-Rokny H; Dehzangi I
    BMC Bioinformatics; 2022 Jul; 23(1):298. PubMed ID: 35879674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of mini-driver genes in the prognosis and tumor features of colorectal cancer samples: a novel perspective to support current biomarkers.
    Campos Segura AV; Velásquez Sotomayor MB; Gutiérrez Román AIF; Ortiz Rojas CA; Murillo Carrasco AG
    PeerJ; 2023; 11():e15410. PubMed ID: 37214090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
    Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
    Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.
    Mohd Yunos RI; Ab Mutalib NS; Tieng FYF; Abu N; Jamal R
    Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32245111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major driver mutations are shared between sinonasal intestinal-type adenocarcinoma and the morphologically identical colorectal adenocarcinoma.
    Sjöstedt S; Schmidt AY; Vieira FG; Willemoe GL; Agander TK; Olsen C; Nielsen FC; von Buchwald C
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1019-1027. PubMed ID: 33051725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy.
    Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
    J Cell Physiol; 2019 May; 234(5):5601-5612. PubMed ID: 30341899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients.
    Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS
    World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
    Escobar D; Bushara O; Sun L; Liao J; Yang GY
    Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
    Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
    Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
    Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
    Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subtypes in early colorectal cancer associated with clinical features and patient prognosis.
    Gil-Raga M; Jantus-Lewintre E; Gallach S; Giner-Bosch V; Frangi-Caregnato A; Safont-Aguilera MJ; Garde-Noguera J; Zorraquino-Pina E; García-Martínez M; Camps-Herrero C
    Clin Transl Oncol; 2018 Nov; 20(11):1422-1429. PubMed ID: 29802524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
    Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
    Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular phenotypes of colorectal cancer is critical in clinical individual treatment].
    Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):994-7. PubMed ID: 26499143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of somatic SMAD4 mutations in colorectal liver metastases.
    Xourafas D; Mizuno T; Cloyd JM
    Chin Clin Oncol; 2019 Oct; 8(5):52. PubMed ID: 31500428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC.
    He Y; Dai X; Chen Y; Huang S
    Genet Res (Camb); 2022; 2022():1831211. PubMed ID: 35975176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Insights Into Colorectal Carcinoma.
    Requena DO; Garcia-Buitrago M
    Arch Med Res; 2020 Nov; 51(8):839-844. PubMed ID: 32962865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    Myte R; Gylling B; Häggström J; Schneede J; Löfgren-Burström A; Huyghe JR; Hallmans G; Meyer K; Johansson I; Ueland PM; Palmqvist R; Van Guelpen B
    PLoS One; 2018; 13(4):e0196233. PubMed ID: 29694444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.